Medtronic and Eli Lilly join forces to tackle Parkinson's
This article was originally published in Clinica
Two giants from the pharma and medtech industries, Eli Lilly and Medtronic, are combining their respective know-how in novel biologic compounds and targeted drug delivery technologies to develop a new treatment for Parkinson's disease.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.